P427Influence of ranolazine on cardioversion rate in patients with new onset atrial fibrillation and ischemic disease of the heart
Sign Up to like & getrecommendations! Published in 2020 at "Europace"
DOI: 10.1093/europace/euaa162.337
Abstract: Ranolazine is a piperazine derivative, mainly used as antianginal drug in patients with ischemic disease of the heart (IDH). Despite its antianginal effect, it has an antiarrhythmic effect by inhibiting of late sodium and rapid… read more here.
Keywords: ischemic disease; patients new; group; disease heart ... See more keywords